Patient Characteristics, Persistence to Treatment and Outcome Events in Patients Treated With Ticagrelor 60 mg After Myocardial Infarction in Real-world Clinical Practice

CompletedOBSERVATIONAL
Enrollment

7,035

Participants

Timeline

Start Date

September 25, 2020

Primary Completion Date

June 28, 2021

Study Completion Date

June 28, 2021

Conditions
Myocardial Infarction (MI)
Trial Locations (6)

20814

Research Site, Bethesda

02451

Research Site, Waltham

Unknown

Research Site, Wismar

Research Site, Rome

Research Site, Stockholm

Research Site, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY